Cargando…

Understanding the impact of RapidArc therapy delivery errors for prostate cancer

The purpose of this study is to simulate random and systematic RapidArc delivery errors for external beam prostate radiotherapy plans in order to determine the dose sensitivity for each error type. Ten prostate plans were created with a single 360° arc. The DICOM files for these treatment plans were...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliver, Mike, Bush, Karl, Zavgorodni, Sergei, Ansbacher, Will, Beckham, Wayne A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718657/
https://www.ncbi.nlm.nih.gov/pubmed/21844850
http://dx.doi.org/10.1120/jacmp.v12i3.3409
_version_ 1783284357417402368
author Oliver, Mike
Bush, Karl
Zavgorodni, Sergei
Ansbacher, Will
Beckham, Wayne A.
author_facet Oliver, Mike
Bush, Karl
Zavgorodni, Sergei
Ansbacher, Will
Beckham, Wayne A.
author_sort Oliver, Mike
collection PubMed
description The purpose of this study is to simulate random and systematic RapidArc delivery errors for external beam prostate radiotherapy plans in order to determine the dose sensitivity for each error type. Ten prostate plans were created with a single 360° arc. The DICOM files for these treatment plans were then imported into an in‐house computer program that introduced delivery errors. Random and systematic gantry position (0.25°, 0.5°, 1°), monitor unit (MU) (1.25%, 2.5%, 5%), and multileaf collimator (MLC) position (0.5, 1, 2 mm) errors were introduced. The MLC errors were either random or one of three types of systematic errors, where the MLC banks moved in the same (MLC gaps remain unchanged) or opposing directions (increasing or decreasing the MLC gaps). The generalized equivalent uniform dose (gEUD) was calculated for the original plan and all treatment plans with errors introduced. The dose sensitivity for the cohort was calculated using linear regression for the gantry position, MU, and MLC position errors. Because there was a large amount of variability for systematic MLC position errors, the dose sensitivity of each plan was calculated and correlated with plan MU, mean MLC gap, and the percentage of MLC leaf gaps less than 1 and 2 cm for each individual plan. We found that random and systematic gantry position errors were relatively insignificant ([Formula: see text] gEUD change) for gantry errors up to 1°. Random MU errors were also insignificant, and systematic MU increases caused a systematic increase in gEUD. For MLC position errors, random MLC errors were relatively insignificant up to 2 mm as had been determined in previous IMRT studies. Systematic MLC shift errors caused a decrease of approximately [Formula: see text] in the gEUD per mm. For systematic MLC gap open errors, the dose sensitivity was 8.2%/mm and for MLC gap close errors the dose sensitivity was [Formula: see text]. There was a large variability for MLC gap open/close errors for the ten RapidArc plans which correlated strongly with MU, mean gap width, and percentage of MLC gaps less than 1 or 2 cm. This study evaluates the magnitude of various simulated RapidArc delivery errors by calculating gEUED on various prostate plans. PACS numbers: 87.55.x, 87.55.D, 87.55.de, 87.55.dk
format Online
Article
Text
id pubmed-5718657
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57186572018-04-02 Understanding the impact of RapidArc therapy delivery errors for prostate cancer Oliver, Mike Bush, Karl Zavgorodni, Sergei Ansbacher, Will Beckham, Wayne A. J Appl Clin Med Phys Radiation Oncology Physics The purpose of this study is to simulate random and systematic RapidArc delivery errors for external beam prostate radiotherapy plans in order to determine the dose sensitivity for each error type. Ten prostate plans were created with a single 360° arc. The DICOM files for these treatment plans were then imported into an in‐house computer program that introduced delivery errors. Random and systematic gantry position (0.25°, 0.5°, 1°), monitor unit (MU) (1.25%, 2.5%, 5%), and multileaf collimator (MLC) position (0.5, 1, 2 mm) errors were introduced. The MLC errors were either random or one of three types of systematic errors, where the MLC banks moved in the same (MLC gaps remain unchanged) or opposing directions (increasing or decreasing the MLC gaps). The generalized equivalent uniform dose (gEUD) was calculated for the original plan and all treatment plans with errors introduced. The dose sensitivity for the cohort was calculated using linear regression for the gantry position, MU, and MLC position errors. Because there was a large amount of variability for systematic MLC position errors, the dose sensitivity of each plan was calculated and correlated with plan MU, mean MLC gap, and the percentage of MLC leaf gaps less than 1 and 2 cm for each individual plan. We found that random and systematic gantry position errors were relatively insignificant ([Formula: see text] gEUD change) for gantry errors up to 1°. Random MU errors were also insignificant, and systematic MU increases caused a systematic increase in gEUD. For MLC position errors, random MLC errors were relatively insignificant up to 2 mm as had been determined in previous IMRT studies. Systematic MLC shift errors caused a decrease of approximately [Formula: see text] in the gEUD per mm. For systematic MLC gap open errors, the dose sensitivity was 8.2%/mm and for MLC gap close errors the dose sensitivity was [Formula: see text]. There was a large variability for MLC gap open/close errors for the ten RapidArc plans which correlated strongly with MU, mean gap width, and percentage of MLC gaps less than 1 or 2 cm. This study evaluates the magnitude of various simulated RapidArc delivery errors by calculating gEUED on various prostate plans. PACS numbers: 87.55.x, 87.55.D, 87.55.de, 87.55.dk John Wiley and Sons Inc. 2011-05-20 /pmc/articles/PMC5718657/ /pubmed/21844850 http://dx.doi.org/10.1120/jacmp.v12i3.3409 Text en © 2011 The Authors. https://creativecommons.org/licenses/by/3.0/This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Oliver, Mike
Bush, Karl
Zavgorodni, Sergei
Ansbacher, Will
Beckham, Wayne A.
Understanding the impact of RapidArc therapy delivery errors for prostate cancer
title Understanding the impact of RapidArc therapy delivery errors for prostate cancer
title_full Understanding the impact of RapidArc therapy delivery errors for prostate cancer
title_fullStr Understanding the impact of RapidArc therapy delivery errors for prostate cancer
title_full_unstemmed Understanding the impact of RapidArc therapy delivery errors for prostate cancer
title_short Understanding the impact of RapidArc therapy delivery errors for prostate cancer
title_sort understanding the impact of rapidarc therapy delivery errors for prostate cancer
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718657/
https://www.ncbi.nlm.nih.gov/pubmed/21844850
http://dx.doi.org/10.1120/jacmp.v12i3.3409
work_keys_str_mv AT olivermike understandingtheimpactofrapidarctherapydeliveryerrorsforprostatecancer
AT bushkarl understandingtheimpactofrapidarctherapydeliveryerrorsforprostatecancer
AT zavgorodnisergei understandingtheimpactofrapidarctherapydeliveryerrorsforprostatecancer
AT ansbacherwill understandingtheimpactofrapidarctherapydeliveryerrorsforprostatecancer
AT beckhamwaynea understandingtheimpactofrapidarctherapydeliveryerrorsforprostatecancer